Cargando…
Bacteria‐Based Cancer Immunotherapy
In the past decade, bacteria‐based cancer immunotherapy has attracted much attention in the academic circle due to its unique mechanism and abundant applications in triggering the host anti‐tumor immunity. One advantage of bacteria lies in their capability in targeting tumors and preferentially colo...
Autores principales: | Huang, Xuehui, Pan, Jingmei, Xu, Funeng, Shao, Binfen, Wang, Yi, Guo, Xing, Zhou, Shaobing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025040/ https://www.ncbi.nlm.nih.gov/pubmed/33854892 http://dx.doi.org/10.1002/advs.202003572 |
Ejemplares similares
-
Development of a pH-responsive polymersome inducing endoplasmic reticulum stress and autophagy blockade
por: Xu, Funeng, et al.
Publicado: (2020) -
Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies
por: Zhou, Min, et al.
Publicado: (2023) -
A bacteria-based system expressing anti-TNF-α nanobody for enhanced cancer immunotherapy
por: Liu, Lina, et al.
Publicado: (2023) -
Current Status and Future Directions of Bacteria-Based Immunotherapy
por: Tang, Quan, et al.
Publicado: (2022) -
Targeting neoantigens for cancer immunotherapy
por: Zhao, Xuan, et al.
Publicado: (2021)